Leading Clinicians to Present on Advancing Eyecare Technologies
Santa Clara, CA – March 14, 2014 – Topcon Medical Laser Systems, Inc. announced that it will host a Meet the Experts program at the World Ophthalmic Congress in Tokyo, Japan, from April 2 through April 4, 2014. Topcon invites ophthalmologists and experts from around the globe to stop by Booth E-18 and learn more about its world-class laser delivery and imaging technologies, through presentations and discussion sessions on the diagnosis and treatment of retinal disorders.
Key topics will include:
- Photo-Thermal Stimulating Endpoint Management™ (EpM) for Retinal Disorders
- PASCAL® Pattern Laser Technology in Practice for the Treatment of diabetic macular edema (DME) and Central Serous Retinopathy (CSR)
- Practice and Clinical Advantages using Topcon’s Optical Coherence Tomography
A schedule and physician biographies can be located at http://www.tmlsinc.com/wocexperts/.
Physician Presentations:
Wednesday, April 2
Photo-Thermal Stimulating EpM: Novel Approaches to Laser Therapy of the Macula
Daniel Lavinsky, MD | 10:00 -11:00
Spectral-domain OCT: From the Patient to the Population
Praveen Patel, MD | 15:00-16:00
Thursday, April 3
Clinical Significance and Advantages using the En-face OCT (EnView)
Fumi Gomi, MD | 11:00 AM – 12:00 PM
State of the Art Macular and Retinal Laser Treatment: Sub-threshold and Targeted Laser
Prof. Paulo Stanga, MD | 13:00 – 14:00
Successful Combination Laser Therapy Approaches using Endpoint Management for Diabetic Macula Edema
Manish Nagpal, MD | 14:00 - 15:00
Friday, April 4
Advantages of Endpoint Management and PASCAL 577 nm for the treatment of DME and CSR
Daniel Lavinsky, MD | 11:00 - 12:00
Swept-Source OCT Imaging of the Vitreous, Retina and Choroid
Prof. Paulo Stanga, MD | 14:00 - 15:00
About Topcon Medical Laser Systems
Topcon Medical Laser Systems is a division of Topcon Corporation. Located in Santa Clara, CA, the company was founded in January 2004 to develop a new technology for the treatment of ocular disease. Initially developed at Stanford University, and exclusively licensed to TMLS, PASCAL Photocoagulators (Pattern Scanning Lasers) are used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease.